InMode (NASDAQ:INMD) Trading Down 3.5% – Here’s Why

InMode Ltd. (NASDAQ:INMD) traded down 3.5% during mid-day trading on Friday . The stock traded as low as $17.83 and last traded at $17.81. 216,123 shares were traded during trading, a decline of 77% from the average session volume of 948,180 shares. The stock had previously closed at $18.46.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of InMode in a research note on Tuesday, February 4th. Barclays upped their price objective on shares of InMode from $26.00 to $29.00 and gave the company an “overweight” rating in a research note on Wednesday, February 5th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $22.25.

InMode Stock Performance

The stock has a market cap of $1.28 billion, a PE ratio of 7.84 and a beta of 2.07. The stock’s 50-day moving average is $17.90 and its two-hundred day moving average is $17.58.

Hedge Funds Weigh In On InMode

Hedge funds have recently made changes to their positions in the stock. Quarry LP boosted its position in shares of InMode by 154.3% during the 3rd quarter. Quarry LP now owns 3,781 shares of the healthcare company’s stock worth $64,000 after purchasing an additional 2,294 shares during the period. Orion Capital Management LLC acquired a new stake in InMode during the 4th quarter worth approximately $65,000. SBI Securities Co. Ltd. acquired a new stake in InMode during the 4th quarter worth approximately $87,000. Farther Finance Advisors LLC lifted its holdings in InMode by 26.2% during the 4th quarter. Farther Finance Advisors LLC now owns 5,555 shares of the healthcare company’s stock worth $93,000 after buying an additional 1,154 shares in the last quarter. Finally, Covestor Ltd lifted its holdings in InMode by 13.9% during the 4th quarter. Covestor Ltd now owns 5,936 shares of the healthcare company’s stock worth $99,000 after buying an additional 723 shares in the last quarter. Hedge funds and other institutional investors own 68.04% of the company’s stock.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.